TRML: Tourmaline Bio, Inc. Company Short-Term Debt
Diversifying the antibody portfolio across various pathologies minimizes trial failure risks, as reflected in the price action on GURU.Markets, where the indicator stands at 0.00. Tourmaline Bio, Inc. (TRML) bases its business on developing treatments for autoimmune disorders with unmet therapeutic needs. Currently, the startup is deploying its existing capital toward costly clinical trials, ensuring autonomous funding for the development of its innovative products.
Metric breakdowns and analytics for Tourmaline (TRML)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Tourmaline Bio, Inc.|TRML - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Tourmaline Bio, Inc.|TRML - Company Total Debt|Debt to Book Capitalization Ratio Tourmaline Bio, Inc.|TRML - Company Long-Term Liabilities|Company Current Liabilities Tourmaline Bio
Initial company analysis:TRML - Tourmaline Bio
This indicator is calculated as the aggregate of all liabilities with a maturity of up to one year. This metric determines current solvency and the risk of a liquidity shortage. For the emerging biotech Tourmaline Bio, Inc. (TRML), debt control confirms the team's financial stability during the development of immune drugs. The trend in total short-term debt allows for an assessment of the company's actual margin of safety. Analyzing the curve helps investors recognize the threat of a cash gap in a timely manner.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO: Company Current Liabilities|Immunome Bio - Amount of Current Liabilities|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|Short-Term Debt kalvista.com (KALV)|Company Current Liabilities SEPN|Company Short-Term Debts Pieris Pharma|Company Short-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS - Company Current Liabilities|enGene - Company Short-Term Debts|RAPT - Company Short-Term Debts|aerovatetx.com (JBIO) - Company Short-Term Debt|ACRS (Aclaris Therapeutics, Inc) - Company Short-Term Debt|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Short-Term Debt Cabaletta Bio (CABA)|Ventyx Biosciences Inc. - Company Short-Term Indebtedness|Company Short-Term Debts THTX (Theratechnologies Inc)|Avalo Therapeutics Inc (AVTX) - Short-Term Debt|ELDN: Company Current Liabilities|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|ZURA (zurabio.com) - Company Short-Term Debt|ATYR (aTyr) - Company Short-Term Debts|Adagene Corp (ADAG) - Short-Term Debt Volume|Company Short-Term Debt ImageneBio Inc (IMA)|STTK - Short-Term Debt|Equillium - Company Current Liabilities|Company Short-Term Loans and Borrowings CNTB|Immunic Inc - Company Short-Term Debts|Short-Term Debt Volume Atara Biotherapeutics ATRA|inflarx.de (IFRX) - Company Short-Term Debt|Company Short-Term Indebtedness XFOR|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Current Liabilities Celularity Corp (CELU)|Company Current Liabilities INMB (INmune Bio Corp)|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Kezar Life Sciences - Company Current Liabilities|Amount of Current Liabilities SABS (sabbiotherapeutics.com)|AKTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Company Short-Term Debt|Company Current Liabilities GeoVax Corp|Company Short-Term Debt Edesa Biotech, Inc.|Company Short-Term Debt IBIO|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)